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Abstract 
Aim: Antibiotic resistance as one of the most serious health threats worldwide leading to a high rate of 
morbidity and mortality. The aim of present study was to examine the prevalence of nosocomial infections (NIs) 
and pattern of antibiotic resistance in teaching hospitals in Iran 
Methods: This cross-sectional descriptive study was conducted in a period of one year in three teaching 
hospitals and all patients with suspected NIs symptoms were chooses. Among these patients who showed 
antibiotic resistance were included in the study. The samples for clinical test in laboratory were obtained with 
using standard methods and aseptic technique by trained personnel. Antibiotic susceptibility testing was 
performed by Kirby-Bauer’s disk diffusion method on Muller-Hinton agar (Hi Media, Mumbai, India) in 
accordance with the standards of the Clinical Laboratory Standards Institute. 
Results: During one year study, 561 patients with nosocomial infections were recognized and among them 340 
patients (60.6%) showed some level of antibiotic resistance. The most common cause of NIs in present study 
was Acinetobacter and the most type of infection was respiratory system infections (52.7%). The highest 
resistance rate was against Ciprofloxacin (61.8%) followed by Imipenem (50.3%). 
Conclusion: Rate of NIs and antibiotics resistance is high in Iranian hospital. So Iranian health ministry should 
provide guideline and suitable programs for prevention of NIs and antibiotic therapy in hospitals. 
Keywords: epidemiology, hospital infections, antibiotic resistance, developing country 
1. Introduction 
Nosocomial infections (NI), also known as hospital acquired infections, are global health problem which affect 
both developed and developing countries. Nosocomial infections are defined as infections occur within 48 hours 
after hospital admission, 3 days after discharge or 30 days after an operation (WHO, 2002). Prevalence of NIs 
are varies between 1.5 to 26.1 percent among different countries (Hashemi et al., 2010; Leaper et al., 2004; Kim 
et al., 2000; Gastmeier et al., 2001; Haley et al., 1985; Behnke et al., 2013; Petersen et al., 2010; Hughes et al., 
2005; Nguyen et al., 2001; Balkhy et al., 2006; Saleem et al., 2013). Prevalence of NIs in Iranian hospitals 
reported between %1.3 to %10 (Hashemi et al., 2010; Askarian et al., 2012; Hajibagheri et al., 2006; 
Qorbanalizadehgan et al., 2008; Barak et al., 2012; Hojat et al., 2012; Hosseinrezaei et al., 2012). The increasing 
rate of NIs, causes more antibiotics usage which leads to economic burden, and as a final result, the increases 
rates of morbidity and mortality (Inweregbu et al., 2005; WHO, 2002; Hashemi et al., 2010). Despite 
international efforts to control NIs during past decades, NIs still remains a prevalent problem and one of patients 
antibiotic resistance causes in hospitals (Farr et al., 2001). 
As the result of broad uses of antimicrobial agents, the infections pathogens have shifted to more resistant 
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bacteria and this causes great problems for nosocomial infections control, prevention and treatment especially for 
hospital infections (Cars et al., 2005). Antibiotic resistance is a natural biological outcome of excess antibiotic 
uses which usually occurs when a microbe acquires a gene, which allows the microbe to inactivate the antibiotic 
activity or nullify its antimicrobial activity (Cars et al., 2005; Muto et al., 2003). The rapid development of 
antimicrobial resistance and its dissemination and burden become a serious public health worldwide, as WHO 
emphasized its importance on World Health Day 2011 (WHO., 2012). According to the CDC report, more than 
70% of the bacteria causing NIs are resistant to at least one of the medications used to treat them (CDC, 2001). 
Also these infections have been more costly and more deadly than those are antibiotic susceptible strains of the 
same species (Muto, 2005). 
There are many important affecting factors which may increase the risk of antibiotic resistance such as poor 
utilization of antimicrobial agents, transmission of resistant bacteria from patient to patient and from health care 
team members to patients, lack of guidelines for appropriate and judicious use of antimicrobial agents and lack 
of easy-to-use auditing tools for restriction and misuse of antimicrobial agents in the animal industry (Aly et al., 
2012).  
Although the resistance against antibiotics is high in Iranian hospitals, the pattern of this antimicrobial resistance 
has not been received enough attention. In a study performed in 2010, Ghadiri and colleagues reported that the 
most prevalent blood stream and urinary tract infections pathogens were Coagulase-negative staphylococci and 
Escherichia coli, respectively. The highest resistance rate of Coagulase-negative staphylococci and Escherichia 
coli was against Penicillin (91.1%) and Nalidixic acid (57.7%) (Ghadiri et al., 2012). In another study, Vahdani 
and colleagues investigated the prevalence of antibiotic resistance to Acinetobacter baumannii in a hospital in 
Tehran, Iran. They showed Acinetobacter baumannii resistance to Ceftazidime (96%), Ceftizoxime (95%), 
Ceftriaxon (93%), Amikacin (58%), Gentamicin (68%), Co-terimoxazole (85%), and Ciprofloxacin (85%) 
(Vahdani et al., 2011). 
It is obvious that knowing about NI rate, the prevalent pathogens, and their antibiotic resistant pathogens is 
essential for effective decision-making on infection control policies, the rational formulation of public health 
care policies, the effective antibiotics therapy, the appropriate antibiotics usage guidelines and the national and 
international research agendas in this area, especially in countries with higher antibiotic use such as Iran. 
Although, broad-spectrum antibiotics are used for infection therapy especially for NIs in Iran, there is limited 
data on antibiotic resistance. So in the present study we examine the prevalence of NIs and pattern of antibiotic 
resistance in three teaching hospitals in southeast of Iran. 
2. Materials and Methods 
This cross-sectional descriptive study performed between January 2012 and January 2013 in three teaching 
hospitals (Afzalipoor, Shahid Bahonar and Shafa) in Kerman, a province in south east of Iran. These three 
hospitals provide the most important medical services of all parts of Kerman province. This project approval was 
obtained from both research center for Tropical and Infectious Diseases of Kerman University of Medical 
Sciences and the heads of the three mentioned hospitals prior to the study.  
Inclusion criteria: All patients with nosocomial infections symptoms, who stayed more than 48 hour in hospitals 
and with no sign of bacterial colonization (like fever) at the time of admission, were chosen. Among these 
patients, the antibiotic susceptibility tests were done for those showed the symptoms of resistance to the 
prescribed antibiotic and patients with positive antibiotic resistance test were included in the study. Samples of 
blood, urine, sputum and wound secretion were obtained using standard methods and aseptic technique by 
trained personnel (physician and nurse). Antibiotic susceptibility testing also was performed by Kirby-Bauer’s 
disk diffusion method on Muller-Hinton agar (Hi Media, Mumbai, India) in accordance with the standards of the 
Clinical Laboratory Standards Institute (CLSI, formerly National Committee for Clinical Laboratory Standards 
[NCCLS]) guidelines (CLSI., 2008). The antibiotic concentration per disk was as follows: Amikacin, 
Amoxicillin, Ampicillin, Carbenicillin, cephalexin, Cefazolin, Cefepime, Cefixime, Cefuroxime, Cefotaxime, 
Ceftazidime, Ceftizoxime, Ceftriaxon, Cefuroxime, Cephalothin, Chloramphenicol, Ciprofloxacin, Clindamycin, 
Cloxacillin, Co-trimoxazole, Doxycycline, Erythromycin, Gentamicin, Imipenem, Kanamycin,  Meropenem, 
Nalidixic acid, Nitrofurantoin, Oxacillin, Penicillin, Rancomycine, Tetracycline, Tobramycin and Vancomycin. 
All statistical analyses were performed using SPSS software (version 18.0; PASW Statistics). A variable was 
considered to be statistically significant if p < 0.05. 
3. Results 
During one year study, 561 patients with nosocomial infections were recognized. Of these 320 (57%) were male 
and 241 (43%) were female. The most of patients were in 21-30 years old, in Intensive Care Units and have 
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respiratory system infections. Among 561 patients, 340 patients (60.6%) showed some level of antibiotic 
resistance. Of these 212 (62.4%) were male and 128 (37.6%) were female and most of them (22.1%) were 
between 21-30 years old. Patients who admitted to Intensive Care Units (ICU, CCU, NICU), both adults and 
neonatal, showed more antibiotics resistance compared to patients admitted to other wards. In terms of infection 
site, most infections were related to respiratory system infections (52.7%) followed by surgical site infection 
(31.5%), urinary tract infection (8.5%) and bloodstream infection (2.9%). About length of hospital stay, most of 
patients (51.2%) stayed between 5 and 30 days (Table 1). Among patients with antibiotic resistance, 84.4%, have 
had intravenous canola, 81.7%, urinary indwelling catheter, 59%, endotheracheal tube, 57.5%, mechanical 
ventilation, 24.8%, tracheostomy tube, 9.1%, arterial canola and 2.7% cerebral shunt. In addition, 65.5% of 
patients had at least one surgery. The most common cause of NIs in present study was Acinetobacter (%31.5), 
Klebsiella (%25.3), Pseudomonas (%13.2), Staphylococcus aureus (10%), Escherichia (7.4%) and Citrobacter 
(5%).  
The highest resistance rate was against Ciprofloxacin (61.8%) followed by Imipenem (50.3%), and the lowest 
rate was against Penicillin, Amoxicillin, Rifampine and Ticarcillin (0.3%) (Tables 2). Acinetobacter and 
Escherichia showed the most resistance to Ciprofloxacin and Klebsiella to Imipenem. Staphylococcus aureus 
showed the most resistance to Ceftriaxone, Pseudomonas to Cefazolin and Citrobacter to Gentamicin (Tables 3). 
The results showed that the antibiotic resistance was more prevalent among men than women (p<0.05). The 
results also showed that resistance to some antibiotics such as Meropenem, Imipenem, Clindamycin, 
Ceftazidime, Cefepime and Amikacine was more prevalent in men and resistance to some other antibiotics such 
as Tobramycin, Chloramphenicol, Nalidocic acid and Methicilin was more prevalent among women. The 
findings also revealed that by increasing the length of hospital stay antibiotics resistance also increased (P<0.05). 
Patients in CCU, ICU, NICU and burning ward showed higher rates of antibiotics resistance in comparison with 
the patients of other wards. This difference was also statistically significant (P<0.05). The patients who had 
surgery, mechanical ventilation, cerebral shunt and Total Parenteral Nutrition (TPN) showed higher rates of 
antibiotic resistance, especially to Cefazolin, Cefteriaxone, Ceftizoxime and Cefotaxime (P<0.05).  
 
Table 1. Frequency of Age, Gender, Length of Stay in Hospital, Site of Infection and Admitted Ward 
Variables 
Frequency 
N % 
Sex 
Men 212 62.4 
Women 128 37.6 
Age 
1-10 15 4.4 
11-20 48 14.1 
21-30 75 22.1 
31-40 41 12.0 
41-50 31 9.1 
51-60 44 12.9 
61-70 37 10.9 
71-80 24 7.1 
81-95 25 7.4 
Length of stay in hospital 
<5 days 26 7.6 
5-30 days 140 51.2 
>30 days 174 41.2 
Ward 
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ICU, CCU, NISU 217 63.8 
Burn 56 16.5 
Orthopedic 30 8.8 
Neurology 19 5.6 
Other Wards 18 5.3 
Site of infection 
Respiratory system 179 52.7 
Surgical site  107 31.5 
Urinary tract  29 8.5 
Bloodstream  10 2.9 
Other 15 4.4 
 
Table 2. Frequency of Resistance to Different Antibiotics 
Antibiotics  Resistance % 
Ciprofloxacin  61.8 
Imipenem 50.3 
Gentamicin 44.1 
Amikacine  43.2 
Ceftriaxon  39.7 
Penicillin 0.3 
Amoxicillin 0.3 
Rifampin 0.3 
Ticarcillin 0.3 
 
Table 3. Prevalence of antibiotic resistance by bacteria  
Antibiotics  Acinetobacter Klebsiella Staphylococcus 
aureus 
Pseudomonas Escherichia Citrobacter 
Amikacine 51.2 39.3 52.6 78.2 21.7 37.5 
Cefazolin 30.5 40.9 15.4 85 41.7 37.5 
Cefepime 36.2 21.3 12.8 15.6 4.5 6.3 
Cefixime 6.3 11.6 63.1 25.1 34.8 18.8 
Ceftazidime 25.8 17.2 5.1 37.6 4.5 12.5 
Ceftriaxone  22.5 21.3 70.5 62.6 74.8 37.5 
Cefuroxime 27.9 25.8 25.3 71.9 20 6.3 
Ciprofloxacin  62 48.3 38.1 71.9 91 25 
Gentamicin  29.5 39.3 48.4 46.9 90 43.8 
Imipenem 51.9 49.4 25.6 78.2 46.1 31.3 
Nalidixic acid  4.7 8 15.4 32.1 61.7 12.5 
Co-trimoxazole 14.8 21.3 7.7 28.1 73.6 6.3 
Cephalexin 3.1 3.4 17.9 0 13.6 6.3 
Kanamycin 9.3 1.1 0 15.7 4.5 12.5 
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4. Discussion 
Since knowing the antibiotic resistance pattern is essential for appropriate therapy, we examined the distribution 
of antibiotic resistance in Kerman, Iran. During one year study, 561 patients with nosocomial infections were 
recognized. About 60.6% of patients with NIs showed some level of antibiotic resistance. The results showed 
that the antibiotic resistance was more prevalent among men than women (p<0.05) but in Ghadiri and colleagues 
study the antibiotic resistance was more prevalent among women. Most of patients were between 21-30 years old 
which could be due to preponderance of more NIs patients in this group. However, the young people in working 
age were more vulnerable to antibiotic resistance. Patients who admitted to Intensive Care Units (ICU, CCU, 
NICU) and burn ward showed more antibiotics resistance compared to patients admitted to other wards.  
Factors like host, organism, and treatment may affect length of hospitalization with resistant organisms. In this 
study 51.2% of patients stayed between 5- 30 days at hospital. The findings consistent with some other studies 
showed antibiotics resistance had significant association with the length of hospital stay (Cosgrove, 2006; de 
Kraker et al., 2011). 
The most used invasive devices were intravenous canola (84.4%) and urinary indwelling catheter (81.7%), and 
patients which had invasive devices treatments showed higher rates of antibiotic resistance. In Erbay and 
colleagues study in Turkey mechanical ventilation, nasogastric tube, tracheotomy and orogastric tube were found 
to be significant risk factors for nosocomial infection (Hakan Erbay et al., 2003). So to reduce nosocomial 
infections, minimizing the use of invasive devices and specific disinfection precautions during the application of 
invasive devices could be effective. 
Most infections site was related to respiratory system (52.7%), surgical site (31.5%), urinary tract (8.5%) and 
bloodstream (2.9%). In Burns and colleagues study the most common infection sites were surgical site, 
pneumonia, urinary tract and bloodstream (Burns et al., 2012). 
Results also showed that Acinetobacter and Klebsiella were the most common cause of NIs. This result is 
consistent with other studies in some developing countries in Latin America and South Africa (Sosa et al., 2010). 
Nevertheless in Aly and Balkhy study in six Persian Gulf Arab countries including Saudi Arabia, Qatar, Bahrain, 
Kuwait, Oman, and United Arab Emirates, the most prevalent determined microorganisms were Escherichia coli, 
Klebsiella, Pneumoniae, Pseudomonas aeruginosa, MRSA and Acinetobacter (Aly et al., 2012). In Erbay and 
colleagues study Pseudomonas aeruginosa, Staphylococcus aureus and Acinetobacter were the frequent 
microorganisms (Hakan et al., 2003). 
Highest resistance rate was against Ciprofloxacin (61.8%) followed by Imipenem (50.3%), and the lowest rate 
was against Penicillin, Amoxicillin, Rifampin and Ticarcillin (0.3%). Acinetobacter and Escherichia showed the 
most resistance to Ciprofloxacin, Klebsiella to imipenem, staphylococcus aureus to Ceftriaxon, Pseudomonas to 
Cefazolin and Citrobacter to Gentimicin. Zamini and colleagues study showed that Acinetobacter and 
Escherichia had the most resistance to Ciprofloxacin and Ceftriaxone (Zamani et al., 2014). In Aly and Balkhy 
investigation the Enterobacteriaceae and Staphylococcus aureus had resistance to broad spectrum of third 
generations of cephalosporins and flucloxacillin (i.e., methicillin‐resistant Staphylococcus aureus or MRSA) 
(Aly et al., 2012). Hashemi and colleagues identified the prevalence of antibiotic resistance of Entrobacteriaceae 
strains isolated from hospital-acquired and community-acquired infections in west of Iran. Highest and lowest 
rate of resistance were related to Ampicillin (98.8%) and Piperacillin (3.7%). They also showed that most 
isolates have resistant to Cefazolin, Cefixime, and Co-trimoxazole (Hashemi et al., 2013).  
In some other studies several reasons have demonstrated for nosocomial infections and antimicrobial resistance 
and many of those reasons exist in Iranian hospitals. These reasons including readily available broad spectrum 
antibiotics (such as 3rd and 4th generations of Cephalosporins, Quinolones and Carbapenems), lack of 
antimicrobial usage guidelines and programs (especially in the hospitals where broad spectrum of antimicrobial 
agents are using), lack of new and modern hospitals with suitable architectural designs and enough space for 
proper isolation of infected and colonized patients with multi-drug resistant organisms, lack of intensive system 
and trained and educated personnel for infections control in hospitals and lack of clinical pharmacologist in the 
field of infectious diseases (Goldman and Huskins., 1997, Aly et al., 2012). Furthermore, lack of staff to patients 
ratio (specially nurses to patients ratio in Iran), lack of information about prevalence and incidence of antibiotic 
resistance, use of antibiotics by Iranian people without prescription of physician, availability of most of 
antibiotics in drugstores for people without needs to physicians order (over-the-counter) in Iran, are very 
important and influential. 
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5. Conclusion 
Similar to other developing countries, NIS and antimicrobial resistance has not received enough attention in Iran. 
Results of present study like some other studies showed that the rate of NIs and antibiotics resistance is high in 
Iranian hospitals. Therefore Iranian health ministry should provide guideline and suitable programs for 
prevention of NIs and antibiotic therapy in hospitals especially using infection specialist beside the other 
physicians in hospitals for prescribing appropriate antibiotics, which can prevent the antibiotic resistance to some 
extent and leads to better treatment and sooner discharge of the patients. Moreover, educational and medical 
systems in Iran need to consider training of some well-educated personnel on the prevention and management of 
NIs and antibiotic resistance. Further research needed in this regards in Iran. 
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